Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators (Q73217048)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1997

Language	Label	Description	Also known as
English	Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators	scientific article published on 01 April 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J R Hampton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D J van Veldhuisen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F X Kleber

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A J Cowley

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Ardia

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Block

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Cortina

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Cserhalmi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Follath

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Jensen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Kayanakis

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K I Lie

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Mancia

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A M Skene

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

349

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9057

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

971-977

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of ibopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2910488-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(96)10488-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9100622%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73217048&oldid=1759493900"